The investigators reported that oral AOD-9604 administration in rodent models produced measurable increases in fat oxidation and reductions in body fat, and that direct application of the compound to ex vivo human adipose tissue produced concentration-dependent increases in lipolysis [2]
AOD9604 is a peptide that is considered to be a modified fragment of growth hormone that has been shown to reduce body fat and regulate metabolism
Inositol participates in the action of serotonin, a neurotransmitter known to control mood and appetite
Finally, one very recent study in the USA has demonstrated that in some individuals with neurological symptoms, the presence in the blood of antibodies against this receptor may interfere with the proper uptake of B12 into the brain
The dosage of AOD9604 used in this study or 0.25 mg per injection, was carefully calculated to be molar equivalent to doses of full-length GH shown to be effective in prior rabbit OA studies
Common mistakes that sabotage AOD 9604 results You can do everything right with dosing and still fail if you make these errors: Injecting at wrong times Injecting AOD 9604 after meals or when insulin is elevated dramatically reduces effectiveness